Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Observational 1

Sponsor

Conditions

Neoplasms 13 Pancreatic Neoplasms 6 Breast Neoplasms 6 Ovarian Neoplasms 4 Uterine Cervical Neoplasms 3 Multiple Myeloma 3 Melanoma 3 Lymphoma 3 Thyroid Diseases 2 Prostatic Neoplasms 2 Pancreatic Cyst 2 Neoplasm Metastasis 2 Myasthenia Gravis 2 Mesothelioma, Malignant 2 Lymphoma, Non-Hodgkin 2 Lung Neoplasms 2 Leukemia, Lymphocytic, Chronic, B-Cell 2 Leukemia, Hairy Cell 2 Leukemia 2 Hematologic Neoplasms 2 Endometrial Neoplasms 2 Wilms Tumor 1 Venous Thrombosis 1 Venous Thromboembolism 1 Uveal Melanoma 1 Uterine Cervical Dysplasia 1 Thyroid Nodule 1 Thyroid Neoplasms 1 Thrombosis 1 Testicular Neoplasms 1

Interventions

tremelimumab 1 durvalumab 1 High-Throughput Nucleotide Sequencing 1 Heavy Ion Radiotherapy 1 Data Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Rare Diseases × Data Collection × Clear all

NCT05773651 2024-10-01

STEP 2 0

University Hospital Tuebingen

10,000 enrolled

Rare Diseases

Data powered by HemOnc (CC BY 4.0) Colophon ⚡